Literature DB >> 9371216

Effect of growth hormone on human alveolar macrophage oxidative metabolism.

M P Keane1, R Coakley, R Costello, S J O'Neill.   

Abstract

BACKGROUND: Growth hormone (GH) has diverse immunological actions and has been shown to augment oxidative metabolism in rat peritoneal and porcine alveolar macrophages and both human and animal neutrophils. A study was performed to determine the effects of GH on human alveolar macrophages in vitro.
METHODS: Macrophages were harvested from 10 patients undergoing bronchoalveolar lavage and incubated with 0, 10 and 100 nmol/ml GH for four hours. Oxidative metabolism was assessed by means of a fluorescent assay using FMLP and E coli as stimulants. Fluorescence was measured using flow cytometry.
RESULTS: No difference in basal or stimulated oxidative metabolism was found between the GH and control groups.
CONCLUSIONS: GH does not have a direct stimulatory action on human alveolar macrophages in vitro. However, this does not exclude an indirect effect in vivo. The results contrast with previous studies on animal alveolar macrophages.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9371216      PMCID: PMC1758634          DOI: 10.1136/thx.52.9.818

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  9 in total

Review 1.  Growth hormone, lymphocytes and macrophages.

Authors:  K W Kelley
Journal:  Biochem Pharmacol       Date:  1989-03-01       Impact factor: 5.858

2.  The effect of growth hormone on weight gain and pulmonary function in patients with chronic obstructive lung disease.

Authors:  G S Pape; M Friedman; L E Underwood; D R Clemmons
Journal:  Chest       Date:  1991-06       Impact factor: 9.410

3.  Specific growth hormone receptors on human peripheral mononuclear cells: reexpression, identification, and characterization.

Authors:  W Kiess; O Butenandt
Journal:  J Clin Endocrinol Metab       Date:  1985-04       Impact factor: 5.958

4.  A fast and easy method to determine the production of reactive oxygen intermediates by human and murine phagocytes using dihydrorhodamine 123.

Authors:  A Emmendörffer; M Hecht; M L Lohmann-Matthes; J Roesler
Journal:  J Immunol Methods       Date:  1990-08-07       Impact factor: 2.303

5.  Enhancement of human granulopoiesis in vitro by biosynthetic insulin-like growth factor I/somatomedin C and human growth hormone.

Authors:  S Merchav; I Tatarsky; Z Hochberg
Journal:  J Clin Invest       Date:  1988-03       Impact factor: 14.808

6.  Production of immunoreactive growth hormone by mononuclear leukocytes.

Authors:  D A Weigent; J B Baxter; W E Wear; L R Smith; K L Bost; J E Blalock
Journal:  FASEB J       Date:  1988-09       Impact factor: 5.191

7.  Lymphocyte subset distribution and natural killer activity in growth hormone deficiency before and during short-term treatment with growth hormone releasing hormone.

Authors:  W Kiess; S Malozowski; M Gelato; O Butenand; H Doerr; B Crisp; E Eisl; A Maluish; B H Belohradsky
Journal:  Clin Immunol Immunopathol       Date:  1988-07

8.  Growth hormone augments superoxide anion secretion of human neutrophils by binding to the prolactin receptor.

Authors:  Y K Fu; S Arkins; G Fuh; B C Cunningham; J A Wells; S Fong; M J Cronin; R Dantzer; K W Kelley
Journal:  J Clin Invest       Date:  1992-02       Impact factor: 14.808

9.  Human and murine cytotoxic T lymphocyte serine proteases: subsite mapping with peptide thioester substrates and inhibition of enzyme activity and cytolysis by isocoumarins.

Authors:  S Odake; C M Kam; L Narasimhan; M Poe; J T Blake; O Krahenbuhl; J Tschopp; J C Powers
Journal:  Biochemistry       Date:  1991-02-26       Impact factor: 3.162

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.